Veterans and Agent Orange: Update 11 (2018) (2018)
Chapter: Appendix A: Public Meeting Agendas
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
References
Appendix A
Next Chapter: Appendix B: Committee and Staff Biographies
Suggested Citation:
"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press.
doi: 10.17226/25137.
Appendix A
Public Meeting Agendas
FIRST PUBLIC MEETING
March 2, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001
Open Session
| 1:00–1:10 p.m. | Welcome and introductions; conduct of the open session Irva Hertz-Picciotto, Ph.D. – Committee Chair |
| 1:10–2:00 p.m. | Charge to the committee and discussion Peter R. Rumm, M.D., M.P.H. – Director, Pre-9/11 Era Environmental Health Program, Department of Veterans Affairs (VA), with Dr. R. Loren Erickson, Chief Consultant, Post-Deployment Health Services |
| 2:00–2:45 p.m. | Overview of VA’s Vietnam Era Health Retrospective Observational Study (VE-HEROeS) Victoria Davey, Ph.D., M.P.H., R.N. – Principal Investigator, VA |
Suggested Citation:
"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press.
doi: 10.17226/25137.
| 2:45–3:30 p.m. | VA Health Care Utilization for Vietnam Veterans Aaron I. Schneiderman, Ph.D., M.P.H., R.N. – Director, Epidemiology Program Post-Deployment Health Services, VA |
| 3:30–4:30 p.m. | Public comments Thomas Berger, Ph.D., Vietnam Veterans of America Ann Brazeau, MPN Advocacy and Education International Carla L. Dean, Bladder Cancer Foundation of Florida Cindy Fabbri MSgt LeRoy G. Foster Raajit K. Rampal, M.D., Ph.D., Memorial Sloan Kettering Cancer Center Rick Weidman, Vietnam Veterans of America |
| 4:30 p.m. | Open session adjourns |
SECOND PUBLIC MEETING
September 7, 2017
Courtyard Marriott Bloomington by Mall of America
7800 Bloomington Avenue S.
Lake Hiawatha Room
Bloomington, MN 55425
Open Session
| 1:00–1:10 p.m. | Welcome | Notes on the conduct of the open session | Introduction of participants Irva Hertz-Picciotto, Ph.D. – Committee Chair |
| 1:10–2:30 p.m. | Presentations and comments by participants and questions from the committee Ronald R. Bach, Ph.D. Robert Behrens Richard Bergling Linda O. Bergum, M.D. Jeremy Eberley and parents Maynard Kaderlick Lee McClary Mokie Porter |
| 2:30 p.m. | Wrap-up and thanks to participants |
Suggested Citation:
"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press.
doi: 10.17226/25137.
THIRD PUBLIC MEETING
November 30, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001
Open Session
| 10:15–10:30 a.m. | Welcome | Notes on the conduct of the open session | Introduction of participants Irva Hertz-Picciotto, Ph.D. – Committee Chair |
| 10:30–11:15 a.m. | Exposures and Heritable Effects Thaddeus (Thad) Schug, Ph.D. – Health Scientist Administrator, Population Health Branch, National Institute of Environmental Health Sciences and the National Toxicology Program |
| 11:15 a.m.–12:00 p.m. | Russian Children’s Study: Dioxins and Semen Quality Russ Hauser, Sc.D. – Frederick Lee Hisaw Professor of Reproductive Physiology. Chair, Department of Environmental Health, Harvard T.H. Chan School of Public Health |
| 12:45–1:30 p.m. | Multiple Myeloma and its Precursor Disease (MGUS) C. Ola Landgren, M.D., Ph.D. – Professor of Medicine and Chief Attending Physician of the Myeloma Service, Memorial Sloan Kettering Cancer Center |
| 1:30–2:15 p.m. | Epidemiology of Glioma Quinn T. Ostrom, Ph.D., M.P.H. – Research Coordinator, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine; Research Manager and Primary Analyst, Central Brain Tumor Registry of the United States |
| 2:15–3:00 p.m. | Glioblastoma – State of the Science Paul S. Mischel, M.D. – Member and Head, Laboratory of Molecular Pathology, Ludwig Institute for Cancer Research San Diego and Professor, Department of Pathology, University of California, San Diego |
Suggested Citation:
"Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2018. Veterans and Agent Orange: Update 11 (2018). Washington, DC: The National Academies Press.
doi: 10.17226/25137.
| 3:00–3:30 p.m. | U.S. Department of Veterans Affairs: Vietnam Veterans and Brain Cancer Ralph L. Erickson, M.D., Dr.P.H., Chief Consultant, Post-Deployment Health Services Peter D. Rumm, M.D., M.P.H., Director, Pre-9/11 Era Environmental Health Program |
| 3:30–4:00 p.m. | Public comments (spoken comments may not exceed 3 minutes per person; written submissions of any length are welcome) Kathy-Lynn Carroll Josenhans Robert M. (Bob) Hunter, Ph.D. Pegi Scarlett Laurel Smith Holt |
| 4:00 p.m. | Open session adjourns |
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.